{"pmid":32349132,"title":"Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?","text":["Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?","Thromb Haemost","Cattaneo, Marco","Bertinato, Elena M","Birocchi, Simone","Brizio, Carolina","Malavolta, Daniele","Manzoni, Marco","Muscarella, Gesualdo","Orlandi, Michela","32349132"],"journal":"Thromb Haemost","authors":["Cattaneo, Marco","Bertinato, Elena M","Birocchi, Simone","Brizio, Carolina","Malavolta, Daniele","Manzoni, Marco","Muscarella, Gesualdo","Orlandi, Michela"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32349132","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1055/s-0040-1712097","e_drugs":["Heparin"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666138495389794304,"score":9.490897,"similar":[{"pmid":32396963,"title":"SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?","text":["SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?","Semin Thromb Hemost","Thachil, Jecko","Srivastava, Alok","32396963"],"journal":"Semin Thromb Hemost","authors":["Thachil, Jecko","Srivastava, Alok"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32396963","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1055/s-0040-1712155","topics":["Mechanism","Diagnosis","Treatment"],"weight":1,"_version_":1666627827801260033,"score":67.628654},{"pmid":32407256,"title":"Acute Pulmonary Embolism and COVID-19.","text":["Acute Pulmonary Embolism and COVID-19.","Radiology","Poyiadi, Neo","Cormier, Peter","Patel, Parth Y","Hadied, Mohamad O","Bhargava, Pallavi","Khanna, Kanika","Nadig, Jeffrey","Keimig, Thomas","Spizarny, David","Reeser, Nicholas","Klochko, Chad","Peterson, Edward L","Song, Thomas","32407256"],"journal":"Radiology","authors":["Poyiadi, Neo","Cormier, Peter","Patel, Parth Y","Hadied, Mohamad O","Bhargava, Pallavi","Khanna, Kanika","Nadig, Jeffrey","Keimig, Thomas","Spizarny, David","Reeser, Nicholas","Klochko, Chad","Peterson, Edward L","Song, Thomas"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32407256","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1148/radiol.2020201955","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666950579844284417,"score":60.42895},{"pmid":32422061,"title":"Thromboembolic Findings in COVID-19 Autopsies: Pulmonary Thrombosis or Embolism?","text":["Thromboembolic Findings in COVID-19 Autopsies: Pulmonary Thrombosis or Embolism?","Ann Intern Med","Deshpande, Charuhas","32422061"],"journal":"Ann Intern Med","authors":["Deshpande, Charuhas"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32422061","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.7326/M20-3255","weight":0,"_version_":1667159284473921537,"score":55.391163},{"pmid":32329221,"title":"Type and dose of heparin in COVID-19.","text":["Type and dose of heparin in COVID-19.","We thank the authors for their comments and feedback on the ISTH interim guidance. Hyper-coagulability is indeed a significant issue in COVID-19 and the haemostatic system is shifted markedly towards the procoagulant side in these patients. However, we cannot yet be certain that unfractionated heparin (UFH) is better than low molecular weight heparin (LMWH) in this scenario. Although UFH has been used for several years, it does have practical issues, mainly with respect to the need for frequent monitoring using the activated partial thromboplastin times (aPTT).","J Thromb Haemost","Thachil, Jecko","Tang, Ning","Gando, Satoshi","Falanga, Anna","Levi, Marcel","Clark, Cary","Iba, Toshiaki","Cattaneo, Marco","32329221"],"abstract":["We thank the authors for their comments and feedback on the ISTH interim guidance. Hyper-coagulability is indeed a significant issue in COVID-19 and the haemostatic system is shifted markedly towards the procoagulant side in these patients. However, we cannot yet be certain that unfractionated heparin (UFH) is better than low molecular weight heparin (LMWH) in this scenario. Although UFH has been used for several years, it does have practical issues, mainly with respect to the need for frequent monitoring using the activated partial thromboplastin times (aPTT)."],"journal":"J Thromb Haemost","authors":["Thachil, Jecko","Tang, Ning","Gando, Satoshi","Falanga, Anna","Levi, Marcel","Clark, Cary","Iba, Toshiaki","Cattaneo, Marco"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32329221","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jth.14870","locations":["heparin"],"e_drugs":["Heparin, Low-Molecular-Weight","Heparin"],"topics":["Treatment"],"weight":1,"_version_":1666138494688296960,"score":53.844917},{"pmid":32405161,"pmcid":"PMC7219417","title":"D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.","text":["D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.","Objective: To analyze the risk factors for pulmonary embolism (PE) in patients infected with COVID-19. Methods: We conducted an observational, retrospective study. Patients with severe infection with COVID-19 and suspected PE were included. Results: Patients with higher levels of D-dimer and those requiring intubation were at a higher risk of developing PE. Higher D-dimer levels were associated with a greater probability of PE 3, 6, 9 and 12 days after determining D-dimer levels with an OR of 1.7, 2.0, 2.4 and 2.4, respectively. Conclusion: In conclusion, patients infected with COVID-19 requiring OTI with higher levels of D-dimer have an increased risk of developing PE.","Respir Med","Garcia-Olive, Ignasi","Sintes, Helena","Radua, Joaquim","Capa, Jorge Abad","Rosell, Antoni","32405161"],"abstract":["Objective: To analyze the risk factors for pulmonary embolism (PE) in patients infected with COVID-19. Methods: We conducted an observational, retrospective study. Patients with severe infection with COVID-19 and suspected PE were included. Results: Patients with higher levels of D-dimer and those requiring intubation were at a higher risk of developing PE. Higher D-dimer levels were associated with a greater probability of PE 3, 6, 9 and 12 days after determining D-dimer levels with an OR of 1.7, 2.0, 2.4 and 2.4, respectively. Conclusion: In conclusion, patients infected with COVID-19 requiring OTI with higher levels of D-dimer have an increased risk of developing PE."],"journal":"Respir Med","authors":["Garcia-Olive, Ignasi","Sintes, Helena","Radua, Joaquim","Capa, Jorge Abad","Rosell, Antoni"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405161","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.rmed.2020.106023","keywords":["covid-19","d-dimer","pulmonary embolism"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666802845509222400,"score":53.201088}]}